Gene · 116844
Papers1,817
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,817
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Comparative efficiency of leucine-rich alpha-2 glycoprotein and fecal calprotectin to assess endoscopic activity in Crohn's disease: a prospective observational study. | Inflamm Bowel Dis | 2026 | 42298226 | PubTator, text mining | PubMed |
| Circulating immunometabolic markers associated with sarcopenia and muscle strength at high altitude: An integrated multi-omics study. | J Nutr Health Aging | 2026 | 42275841 | PubTator, text mining | PubMed |
| LRG1 as a Potential Therapeutic Target in Atherosclerosis: Mechanistic Basis and Current Evidence. | Cells | 2026 | 42193941 | PubTator, text mining | PubMed |
| Serum LRG1 as a diagnostic marker of necrotizing enterocolitis in preterm infants. | Front Pediatr | 2026 | 42158368 | PubTator, text mining | PubMed |
| Identification and validation of lactylation-related genes signature and immune infiltration landscape of rheumatoid arthritis based on machine learning. | Hereditas | 2026 | 42135859 | PubTator, text mining | PubMed |
| Leucine-Rich Alpha-2 Glycoprotein Is an Accurate Serum Marker for Endoscopic and Histological Remission in Ulcerative Colitis. | Inflamm Intest Dis | 2026 | 42077409 | PubTator, text mining | PubMed |
| Identification and Integration of LRG1-Induced Differentially Expressed Gene (DEG) Hub Profiles in Breast Cancer Cells. | Int J Mol Sci | 2026 | 42074251 | PubTator, text mining | PubMed |
| Selective IL-23 inhibitors in ulcerative colitis: current evidence and perspectives for multimodal personalized treatment: a narrative review. | J Gastroenterol | 2026 | 42068359 | PubTator, text mining | PubMed |
| A NETs-centric multi-omics framework prioritizes PGLYRP1 and MMP9 as subtype-associated thromboinflammatory biomarker candidates and putative therapeutic hypotheses in ischemic stroke. | Neurobiol Dis | 2026 | 42066918 | PubTator, text mining | PubMed |
| Elevated leucine-rich alpha-2 glycoprotein levels and mortality risk in end-stage renal disease: evidence for gender differences. | Clin Kidney J | 2026 | 42017030 | PubTator, text mining | PubMed |
| Diabetic retinopathy: Research advances in canonical cellular pathways and emerging mechanisms. | Exp Eye Res | 2026 | 41985866 | PubTator, text mining | PubMed |
| An exosome-related gene signature predicts prognosis, immune suppression, and therapeutic sensitivity in luminal breast cancer. | Discov Oncol | 2026 | 41975138 | PubTator, text mining | PubMed |
| Hepatocyte-derived LRG1 primes the liver for metastasis and impairs immunotherapy. | Cell Mol Immunol | 2026 | 41963620 | PubTator, text mining | PubMed |
| Selective Drug-Free Active Surveillance in Ulcerative Colitis: Biomarker-Guided, Patient-Centered Approach. | JGH Open | 2026 | 41958468 | PubTator, text mining | PubMed |
| Monocyte Chemokines Enhance Atherosclerotic Plaque Necrosis After Bacterial Kidney Infection. | FASEB J | 2026 | 41930659 | PubTator, text mining | PubMed |
| Proteomic biomarkers for early diagnosis and prognosis in pediatric sepsis. | World J Clin Pediatr | 2026 | 41884028 | PubTator, text mining | PubMed |
| Changes in Maternal Leucine-Rich α-2 Glycoprotein Levels During Pregnancy: Comparison Between Preterm and Term Births. | Cureus | 2026 | 41869115 | PubTator, text mining | PubMed |
| Extracellular payload release from non-internalizing antibody-drug conjugates: mechanisms and linker technologies. | Drug Deliv | 2026 | 41866709 | PubTator, text mining | PubMed |
| Exosomes in diabetic kidney disease: pathogenesis, biomarker discovery, and emerging therapeutics-a comprehensive systematic review. | Ren Fail | 2026 | 41845912 | PubTator, text mining | PubMed |
| Plasma Proteomic Signatures of Pediatric Sepsis Reveal Persistent Inflammation and Phase-Specific Biomarkers. | FASEB Bioadv | 2026 | 41815387 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/116844/papers?page=2